Skip to content
Events

Details

The science behind XLEAP-SBSᵀᴹ Chemistry​

In this webinar Pietro Gatti, Associate Director & Future Tech Strategy Lead is joined by the Illumina science team to showcase the research and development that went into building the new XLEAP-SBS Chemistry.

Complete the form to access the On Demand webinar

Your email address is never shared with third parties.

Date & Time
20 Mar 2024
Location
Europe
Affiliation
Associate Director & Future Tech Strategy Lead, Illumina
Presenter
Pietro Gatti
Topic
Cancer research, Cellular & molecular biology, Genetic & rare diseases
Watch Now

Related Events

Feb 18
Single-Cell Sequencing Made Simple
18 Feb 2025
Illumina hosting a webinar on one our latest annocements
View Event
Feb 25
Alzheimer’s Research UK
25 Feb 2025 – 26 Feb 2025
Illumina will be exhibiting at the ARUK 2025. Come and visit us at our booth.
View Event
Feb 26
Illumina’s Integrated Workflow for Rare and Undiagnosed Genetic Disease Research
26 Feb 2025
Individuals suspected of having a rare disease often face a long search for an answer. With up to 80% of rare diseases being genetic or having a genetic subtype, it is imperative to interrogate the genome to find answers and shorten the diagnostic odyssey. This webinar provides an overview of the integrated workflow provided by Illumina for rare and undiagnosed diseases research. Starting from library prep to sequencing and informatics, Illumina empowers researchers to find the answers they seek in rare and undiagnosed disease research.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.